Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Streptococcus pneumoniae: description of the pathogen, disease epidemiology, treatment, and prevention.

Bridy-Pappas AE, Margolis MB, Center KJ, Isaacman DJ.

Pharmacotherapy. 2005 Sep;25(9):1193-212. Review.

PMID:
16164394
2.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
3.

Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.

Picazo JJ.

Clin Microbiol Infect. 2009 Apr;15 Suppl 3:4-6. doi: 10.1111/j.1469-0691.2009.02723.x. Review.

4.

Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.

Pavia M, Bianco A, Nobile CG, Marinelli P, Angelillo IF.

Pediatrics. 2009 Jun;123(6):e1103-10. doi: 10.1542/peds.2008-3422.

PMID:
19482744
5.

National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.

Hsieh YC, Lin PY, Chiu CH, Huang YC, Chang KY, Liao CH, Chiu NC, Chuang YC, Chen PY, Chang SC, Liu JW, Yen MY, Wang JH, Liu CY, Lin TY.

Vaccine. 2009 Sep 4;27(40):5513-8. doi: 10.1016/j.vaccine.2009.06.091. Epub 2009 Jul 17.

PMID:
19615960
6.

Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.

Harboe ZB, Valentiner-Branth P, Benfield TL, Christensen JJ, Hjuler T, Kaltoft M, Krogfelt KA, Lambertsen L, Konradsen HB.

Vaccine. 2008 Jul 4;26(29-30):3765-71. doi: 10.1016/j.vaccine.2008.04.040. Epub 2008 May 5.

PMID:
18513840
7.

Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.

Pletz MW, Maus U, Krug N, Welte T, Lode H.

Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Review.

PMID:
18378430
8.

Clinical experience with pneumococcal conjugate vaccines in infants and children.

Jackson CR.

J Am Osteopath Assoc. 2002 Aug;102(8):431-6. Review.

PMID:
12201547
9.

Understanding the link between pneumococcal serotypes and invasive disease.

Soley C, Arguedas A.

Vaccine. 2009 Aug 21;27 Suppl 3:C19-21. doi: 10.1016/j.vaccine.2009.06.003. Epub 2009 Jun 16.

PMID:
19535183
10.

Antibiotic resistance in Latin America: a cause for alarm.

Valenzuela MT, de Quadros C.

Vaccine. 2009 Aug 21;27 Suppl 3:C25-8. doi: 10.1016/j.vaccine.2009.06.005. Epub 2009 Jun 21.

PMID:
19540634
11.

Children with bacterial meningitis presenting to the emergency department during the pneumococcal conjugate vaccine era.

Nigrovic LE, Kuppermann N, Malley R; Bacterial Meningitis Study Group of the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics.

Acad Emerg Med. 2008 Jun;15(6):522-8. doi: 10.1111/j.1553-2712.2008.00117.x.

12.

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.

Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E, Peto T, Brueggemann AB, Crook DW; Oxford Invasive Pneumococcal Surveillance Group.

J Med Microbiol. 2008 Apr;57(Pt 4):480-7. doi: 10.1099/jmm.0.47690-0.

PMID:
18349369
13.

Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention.

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):189-209. doi: 10.1055/s-0029-1202938. Epub 2009 Mar 18. Review.

PMID:
19296419
14.

Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.

Motlova J, Benes C, Kriz P.

Epidemiol Infect. 2009 Apr;137(4):562-9. doi: 10.1017/S0950268808001301. Epub 2008 Sep 16.

PMID:
18796171
15.

[Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)].

Artiles F, Horcajada I, Cañas AM, Alamo I, Bordes A, González A, Santana M, Lafarga B.

Enferm Infecc Microbiol Clin. 2009 Jan;27(1):14-21. doi: 10.1016/j.eimc.2008.03.001. Epub 2009 Jan 9. Spanish.

PMID:
19217998
16.

Rethinking recommendations for use of pneumococcal vaccines in adults.

Whitney CG, Schaffner W, Butler JC.

Clin Infect Dis. 2001 Sep 1;33(5):662-75. Epub 2001 Jul 30. Review.

PMID:
11486289
17.

Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.

Ho PL, Chiu SS, Chow FK, Mak GC, Lau YL.

Vaccine. 2007 Sep 28;25(39-40):6837-41. Epub 2007 Aug 7.

PMID:
17714837
18.

Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations.

Adam D, Fehnle K.

Vaccine. 2008 Nov 5;26(47):5944-51. doi: 10.1016/j.vaccine.2008.08.058. Epub 2008 Sep 16.

PMID:
18801402
20.

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.

Clin Infect Dis. 2008 Oct 15;47(8):989-96. doi: 10.1086/591966.

PMID:
18781875

Supplemental Content

Support Center